交易中 05-15 11:57:15 美东时间
-0.150
-0.63%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
Baird analyst Jeff Johnson maintains Envista Holdings (NYSE:NVST) with a Outperform and raises the price target from $30 to $31.
05-07 19:45
华盛资讯5月7日讯,Envista Holdings公布2026财年Q2业绩,公司Q2营收7.06亿美元,同比增长14.4%,归母净利润0.39亿美元,同比增长115.0%。
05-07 09:16
华盛资讯5月7日讯,Envista Holdings公布2026财年Q1业绩,公司Q1营收7.06亿美元,同比增长14.4%,归母净利润0.39亿美元,同比增长115.0%。
05-07 07:55
Envista Holdings shares are trading higher after the company reported better-th...
05-07 05:23
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
今日重点评级关注:瑞银:维持SS&C科技"买入"评级,目标价从112美元升至115美元;Piper Sandler:维持儒博实业"超配"评级,目标价从530美元升至540美元
04-27 14:04
Morgan Stanley analyst Erin Wright maintains Envista Holdings (NYSE:NVST) with a Equal-Weight and raises the price target from $19 to $21.
04-24 20:14
今日重点评级关注:Ascendiant Capital:维持Knightscope"买入"评级,目标价从25美元升至26美元;杰富瑞:维持Allogene疗法"买入"评级,目标价从6美元升至10美元
04-16 10:14
As Q1 2026 earnings season approaches, the healthcare sector enters reporting season as one of the market's primary laggards, with the Health Care Select Sector SPDR Fund (XLV) down 5.29% in Q1 2026, ...
04-11 05:14